Management of Acute Chest Pain in a Patient with Complex Comorbidities and Renal Impairment
The most appropriate management for this 73-year-old male with recent central chest pain, history of MI, metastatic prostate cancer, and severe renal impairment requires urgent cardiology consultation and consideration for a V/Q scan rather than CTPA due to his significantly impaired renal function (eGFR 16).
Clinical Assessment and Risk Stratification
This patient presents with several concerning features:
- Sudden onset central chest pain at rest, described as heavy pressure
- Pain unrelieved by GTN spray and aspirin
- Associated symptoms of sweating and dizziness
- Duration of 1.5 hours
- Pain worse on inspiration
- Significant cardiovascular risk factors: previous MI with stents, AAA, sleep apnea
- Metastatic prostate cancer
- Severe renal impairment (creatinine 318 μmol/L, eGFR 16 mL/min)
- Elevated D-dimer (523)
Differential Diagnosis
Acute Coronary Syndrome (ACS)
- Serial troponins are reassuring (5.7 → 6.7 ng/L, well below the cutoff of 53 ng/L)
- ECG shows known RBBB without new changes
- Pain characteristics somewhat atypical (worse on inspiration)
Pulmonary Embolism (PE)
- Elevated D-dimer (523)
- Pain worse on inspiration
- Low Wells score (1)
Pericarditis
- Recent urosepsis
- Pain worse on inspiration
- Not improved with position changes
Aortic pathology (dissection/aneurysm)
- Known AAA
- Sudden onset severe chest pain
Management Approach
Immediate Management
Renal Function Management 1
- The patient has severe renal impairment (eGFR 16 mL/min, Stage 4 CKD)
- This represents acute kidney injury (AKI stage 1) from baseline creatinine of 178 (eGFR 33)
- Careful IV hydration with isotonic saline
- Monitor fluid status closely to avoid volume overload
- Target urine output of 100-150 mL/hour
Diagnostic Workup for PE
- Despite low Wells score, elevated D-dimer requires further investigation
- V/Q scan is the appropriate choice rather than CTPA due to severe renal impairment
- D-dimer has high sensitivity but decreased specificity in renal impairment 2, 3
- The scheduled V/Q scan is appropriate to avoid contrast-induced nephropathy
Cardiac Assessment
- Serial troponins have been reassuring
- Cardiology consultation has already been obtained
- ECG monitoring for any dynamic changes
Special Considerations for Renal Impairment
Medication Adjustments 1
- Adjust all medication doses according to eGFR of 16 mL/min
- Avoid nephrotoxic medications
- Use caution with anticoagulants if needed
- Avoid iodinated contrast if possible
- If contrast is absolutely necessary:
- Use iso-osmolar contrast agents
- Limit contrast volume based on formula: Maximum contrast volume = 5 mL × body weight (kg)/serum creatinine (mg/dL)
- Ensure adequate hydration before and after procedure
Nephrology Consultation 1
- Indicated due to eGFR <30 mL/min with acute decline from baseline
- May need to consider renal replacement therapy if further deterioration occurs
Follow-up and Ongoing Management
Cardiovascular Risk Management 4, 1
- Continue appropriate secondary prevention medications adjusted for renal function
- Ensure optimal management of sleep apnea with CPAP
- Blood pressure control with appropriate agents
Renal Function Monitoring 1
- Daily monitoring of renal function
- Careful fluid balance assessment
- Avoid further nephrotoxic insults
Cancer Management Considerations
- Coordinate with oncology regarding management of metastatic prostate cancer
- Recent axillary lymph node evaluation showed no evidence of metastases
Potential Pitfalls and Caveats
D-dimer Interpretation in Renal Impairment
Contrast-Induced Nephropathy Risk
Troponin Interpretation
- Troponin levels may be chronically elevated in patients with renal impairment
- Serial measurements showing minimal change are reassuring
Medication Management
- Careful dose adjustment of all medications based on renal function
- Consider nephrology consultation for medication management
This patient requires a careful balance between diagnostic thoroughness and avoiding further renal injury. The scheduled V/Q scan is appropriate, and continued monitoring of both cardiac and renal status is essential.